COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 157 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,127,000 | -12.9% | 63,566 | 0.0% | 0.05% | -3.9% |
| Q1 2022 | $1,294,000 | +99.1% | 63,566 | +82.7% | 0.05% | +155.0% |
| Q4 2021 | $650,000 | -7.0% | 34,800 | -1.7% | 0.02% | -13.0% |
| Q3 2021 | $699,000 | -17.2% | 35,400 | -0.8% | 0.02% | -17.9% |
| Q2 2021 | $844,000 | -0.2% | 35,700 | 0.0% | 0.03% | -6.7% |
| Q1 2021 | $846,000 | +25.0% | 35,700 | +5.6% | 0.03% | +30.4% |
| Q4 2020 | $677,000 | -5.7% | 33,800 | -2.0% | 0.02% | -4.2% |
| Q3 2020 | $718,000 | +12.0% | 34,498 | -5.7% | 0.02% | +41.2% |
| Q2 2020 | $641,000 | -16.0% | 36,598 | -21.7% | 0.02% | -26.1% |
| Q1 2020 | $763,000 | -6.4% | 46,742 | +18.0% | 0.02% | +21.1% |
| Q4 2019 | $815,000 | +77.6% | 39,600 | -1.0% | 0.02% | +90.0% |
| Q3 2019 | $459,000 | -13.2% | 40,000 | -0.5% | 0.01% | -16.7% |
| Q2 2019 | $529,000 | – | 40,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |